People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vicapsys Life Sciences, Inc. | — | Biotechnology | Pre-Seed | $800K | $2.9M | 2023 |
Charlie Farrahar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charlie Farrahar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Rosenblum | 1 | 6 |
| Colleen Delaney | 1 | 4 |
| Robert P. Grammen | 1 | 3 |
| Jeffrey Wright | 1 | 2 |
| Frederico P. Pier | 1 | 1 |
| Michael W. Yurkowsky | 1 | 1 |
| Larry M. Glasscock | 1 | 1 |
| Ryan E. Seddon | 1 | 1 |
| Federico Pier | 1 | 1 |
| Dorothy Jordan | 1 | 1 |
| Rodger E. Rees | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.